
by Asssociated Press
Published: Mon, August 24, 2009 - 7:27 pm CST
Last Updated: Mon, August 24, 2009 - 7:33 pm CST
WASHINGTON (AP) - The Food and Drug Administration isinvestigating reports of liver damage in patients taking alli, the
only nonprescription weight loss drug approved by the agency.
Regulators say they have received more than 30 reports of liver
damage in patients taking alli and Xenical, the prescription
version of the drug. Twenty-seven patients had to be hospitalized,
and six suffered liver failure.
Alli and Xenical are both marketed by British drugmaker
GlaxoSmithKline, though Xenical is manufactured by Swiss firm
Roche.
The FDA says it has not established a definitive relationship
between the weight loss drugs and liver injury.
The agency says patients should continue using the drugs as
directed.
FDA Probes Weight Loss Drug Liver Damage










Recently Commented On
Health Care Bill Clears First…
Driver Loses Control Hitting…
WKRG Digital Signal Upgrade
Siran Stacy Sues Dothan 911…
Baldwin School Closing A Possibility?